Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
- Characterization and Clinical Outcomes of Severe Asthma Patients in Israel Treated With Benralizumab (SAIL-B)Active Not Recruiting
Sponsor: AstraZeneca
Severe Asthma
Israel
Sponsor: Tempus AI
Small Cell Lung Cancer
United States
- Real-life Treatment Outcomes of Ravulizumab in PNHActive Not Recruiting
Sponsor: AstraZeneca
Paroxysmal Nocturnal Haemoglobinuria
Poland
Sponsor: Tempus AI
Head and Neck Squamous Cell Carcinoma
United States, Puerto Rico
Sponsor: AstraZeneca
Asthma
United States
- AI-based Echocardiography for Detection of Cardiac AmyloidosisNot Yet Recruiting
Sponsor: Germans Trias i Pujol Hospital
Cardiac Amyloidosis · Heart Failure With Preserved Ejection Fraction (HFPEF) · Left Ventricular Hypertrophy
Sponsor: Daiichi Sankyo
Breast Cancer
United States, Australia, Belgium, Brazil, China +5 more
- A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor MutationsActive Not Recruiting
Sponsor: AstraZeneca
Non-Small Cell Lung Cancer (NSCLC)
Hong Kong, Malaysia, Singapore, South Korea, Taiwan +1 more
- Human ADME Study of [14C]-AZD1390Not Yet Recruiting
Sponsor: AstraZeneca
Advanced Solid Malignancies
United Kingdom
- Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With OlaparibActive Not Recruiting
Sponsor: AstraZeneca
Ovarian Cancer · Breast Cancer
United States, Belgium, Bulgaria, Canada, China +18 more
- A Study in Patients With Myasthenia Gravis in ChinaActive Not Recruiting
Sponsor: AstraZeneca
Myasthenia Gravis
China
Sponsor: AstraZeneca
Breast Cancer
United States, Belgium, Brazil, Chile, Colombia +12 more
- Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)Active Not Recruiting
Sponsor: AstraZeneca
Non Small Cell Lung Carcinoma NSCLC
United States, Australia, China, Hungary, Netherlands +7 more
- DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancErRecruiting
Sponsor: University College, London
Bladder Cancer
United Kingdom
- First in Human Study of AZD9592 in Solid TumorsActive Not Recruiting
Sponsor: AstraZeneca
Advanced Solid Tumours · Carcinoma Non-small Cell Lung · Head and Neck Neoplasms · Colorectal Neoplasms
United States, Australia, Canada, China, France +6 more
- Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO TrialActive Not Recruiting
Sponsor: M.D. Anderson Cancer Center
Extensive Stage Lung Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8 · Stage IVA Lung Cancer AJCC v8 · Stage IVB Lung Cancer AJCC v8
United States
Sponsor: AstraZeneca
Bronchial Asthma
Japan
Sponsor: AstraZeneca
Bronchial Asthma
Japan
- A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS LymphomasActive Not Recruiting
Sponsor: UNC Lineberger Comprehensive Cancer Center
Central Nervous System Lymphoma
United States
Sponsor: AstraZeneca
Healthy Participants
United States
Sponsor: AstraZeneca
Non-Small Cell Lung Cancer
United States, Belgium, Brazil, Canada, Chile +23 more
- The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2Not Yet Recruiting
Sponsor: Montefiore Medical Center
Non-small Cell Lung Cancer
United States
Sponsor: Women's Cancer Study Group GmbH
HER2-positive Early Breast Cancer
Germany
- EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid CardiomyopathyActive Not Recruiting
Sponsor: AstraZeneca
Transthyretin Amyloid Cardiomyopathy
China
- A Study of GC012F Injection in Subjects With Refractory Systemic Lupus ErythematosusActive Not Recruiting
Sponsor: Gracell Biotechnologies (Shanghai) Co., Ltd.
Refractory Systemic Lupus Erythematosus
China